Bringing Threat to the Fore: Participating in Lifelong Surveillance for Genetic Risk of Cancer

Ellen Giarelli

ONF 2003, 30(6), 945-955. DOI: 10.1188/03.ONF.945-955

Purpose/Objectives: To explain how patients with multiple endocrine neoplasia type 2a (MEN2a) and family members conceptualize participation in lifelong surveillance in genetic cancer care.

Design: Qualitative naturalistic inquiry.

Setting: Northeastern United States. Data were collected during interviews in informants' homes.

Sample: 12 adult patients and 9 family members were recruited pur-posively through endocrinology clinics at two East Coast medical centers.

Methods: A grounded theory design was used. Subjects completed a demographic questionnaire and were interviewed on two occasions. In-depth interviews were audiotaped. The core concept and process variables emerged through three levels of narrative content analysis, theoretical sampling, and constant comparison. The generated theory was presented to the participants for validation.

Main Research Variables: The basic psychological issue associated with participation in lifelong surveillance and the psychosocial processes used by individuals to deal with the issues.

Findings: MEN2a patients and family members experience surveillance as a (Re)Minding of a threat to health. Once threat is brought to the fore, participants interpret the meaning and negotiate control of the impact of the diagnosis, related events, and consequences. Meaningful information from surveillance activities is incorporated into participants' self-image and daily lives through a process of (Re)Integration. The genetic nature of MEN2a did not emerge as a significant subcategory in relation to the core variable.

Conclusions: Finding meaning in the outcomes of surveillance events is a psychosocial process that is central to participation in lifelong surveillance. Genetic predisposition to cancer was a peripheral concern to subjects as they dealt with surveillance issues.

Implications for Nursing: This investigation provides a model for the development of a grounded theory for understanding how people with other genetic cancer syndromes participate in lifelong surveillance.

Jump to a section

    References

    Allchin-Petardi, L. (1998). Weathering the storm: Persevering through a difficult time. Nursing Science Quarterly, 11, 172-177.

    Anderson, J.M., Elfert, H., & Lai, M. (1989). Ideology in the clinical context: Chronic illness, ethnicity, and the discourse on normalization. Sociology of Health and Illness, 11, 253-278.

    Becker, C., Kraft, J.M., Southwell, B.F., & Jorgensen, C.M. (2000). Colorectal cancer screening in older men and women: Qualitative research findings and implications for intervention. Journal of Community Health, 25, 263-278.

    Benoliel, J.Q. (1967). The nurse and the dying patient. New York: Macmillan.

    Berenson, M., Groshen, S., Miller, H., & DeCosse, J. (1989). Subject-reported compliance in a chemoprevention trial for familial adenomatous polyposis. Journal of Behavioral Medicine, 12, 233-247.

    Blalock, S.J., DeVellis, B.M., & Sandler, R.S. (1987). Participation in fecal occult blood screening: A critical review. Preventive Medicine, 16(1), 9-18.

    Blumer, H. (1969). Symbolic interactionism: Perspective and method. Berkeley, CA: University of California Press.

    Bowes, D.E., Tamlyn, D., & Butler, L.J. (2002). Women living with ovarian cancer: Dealing with an early death. Health Care for Women International, 23, 135-148.

    Charon, J.M. (2001). Symbolic interaction: An introduction, an interpretation, an integration (7th ed.). Upper Saddle River, NJ: Prentice Hall.

    Chi, D.D., & Moley, J.F. (1998). Medullary thyroid carcinoma: Genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia. Surgical Oncology Clinics of North America, 7, 681-706.

    Cleiren, M., Oskam, W., & Lips, C. (1989). Living with a hereditary form of cancer: Experiences and needs of MEN2 patients and their families. Henry Ford Hospital Medical Journal, 37, 164-166.

    Correia, M.J., Lopes, L.O., Bugalho, M.J., Cristina, L., Santos, A.I., Bordalo, A.D., et al. (2000). Multiple endocrine neoplasia type 2a. Study of a family. Reviews in Portuguese Cardiology, 19(1), 11-31.

    Davis, C.S., Zinkand, J.E., & Fitch, M.I. (2000). Cancer treatment-induced menopause: Meaning for breast and gynecological cancer survivors. Canadian Oncology Nursing Journal, 10(1), 14-21.

    de Graaf, J.S., Dullaart, R.P., & Zwierstra, R.P. (1999). Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2—A plea to conserve adrenal function. European Journal of Surgery, 165, 843-846.

    Easton, D., Ponder, M., Cummings, T., Gagel, R., Hansen, H., Reichlin, S., et al. (1989). The clinical and screening age-of-onset distribution for MEN-2 syndrome. American Journal of Human Genetics, 44, 208-215.

    Fontana, A., & Fry, J. (1994). Interviewing: The art of science. In N.K. Denzin & Y.S. Lincoln (Eds.), Handbook of qualitative research (pp. 361-376). London: Sage.

    Fox, D.M., & Gruman, J. (1999). Patients as effective collaborators in managing chronic conditions. Retrieved July 14, 2000, from http://www.millbank.org/990811chronic.html

    Frank-Raue, K., Hoppner, W., Buhr, H., Herfarth, C., & Raue, F. (1997). Results and follow-up in 11 MEN2a gene carriers after prophylactic thyroidectomy. Experiments in Clinical Endocrinology and Diabetes, 105(Suppl. 4), 76-78.

    Gagel, R.F. (1997). Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma impact of genetic screening on management. In A. Arnold (Ed.), Endocrine neoplasms (pp. 421-442). New York: Kluwer Academic.

    Geiger, J., & Thompson, N. (1996). Thyroid tumors in children. Otolaryngology Clinics of North America, 29, 711-719.

    Giarelli, E. (1999). Spiraling out of control: One case of pathologic anxiety as a response to a genetic risk of cancer. Cancer Nursing, 22, 327-339.

    Giarelli, E. (2002). Multiple endocrine neoplasia type 2a (MEN2a): A call for psychosocial research. Psycho-Oncology, 11, 59-73.

    Gimm, O., & Dralle, H. (1999). C-cell cancer—Prevention and treatment. Langenbecks Archives of Surgery, 384(1), 16-23.

    Glaser, B. (1978). Theoretical sensitivity: Advances in the methodology of grounded theory. Mill Valley, CA: Sociology Press.

    Guba, E.G. (1981). Criteria for assessing the trustworthiness of naturalistic inquiries. Educational Communication and Technology Journal, 29(2), 75-91.

    Howe, J., Lairmore, T., Dou, S., Mishra, S., Dilley, W., Donis-Keller, H., et al. (1992). Presymptomatic identification of carriers of the multiple endocrine neoplasia 2a gene using flanking DNA markers. Surgery, 112, 219-225.

    Hundahl, S.A., Fleming, I.D., Fremgen, A.M., & Menck, H.R. (1998). A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer, 83, 2638-2648.

    Hutchinson, S. (2000). Grounded theory: The method. In P. Munhall & C. Boyd (Eds.), Nursing research: A qualitative perspective (2nd ed., pp. 180-213). Boston: Jones and Bartlett.

    Jemal, A., Thomas, A., Murray T., & Thun, M. (2002). Cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 52, 23-47.

    Johnston, L.B., Chew, S.L., Trainer, P.J., Reznek, R., Grossman, A.B., Besser, G.M., et al. (2000). Screening children at risk of developing inherited endocrine neoplasia syndromes. Clinical Endocrinology, 52, 127-136.

    Keiser, H.R., Beaven, M.A., Doppman, J., Wells, S.A., Jr., & Buja, L.M. (1997). Sipple's syndrome: Medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Annals of Internal Medicine, 78, 561-579.

    Knafle, K.A., & Deatrick, J.A. (1986). How families manage chronic conditions: An analysis of the concept of normalization. Research in Nursing and Health, 9, 215-222.

    Lairmore, T.C., Frisella, M.M., & Wells, S.A., Jr. (1996). Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma. Annals of Medicine, 28, 401-406.

    Lammers, S.E., Schaefer, K.M., Ladd, E.C., & Echenberg, R. (2000). Caring for women living with ovarian cancer: Recommendations for advanced practice nurses. Journal of Obstetric, Gynecologic and Neonatal Nursing, 29, 567-573.

    Learoyd, D., Marsh, D., Richardson, A., Twigg, S., Delbridge, L., & Robinson, B. (1997). Genetic testing for familial cancer: Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Archives of Surgery, 132, 1022-1025.

    Ledger, G., Khosla, S., Lindor, N., Thibodeau, S., & Gharib, H. (1995). Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Annals of Internal Medicine, 122, 118-124.

    Matthews, D., & Hingson, R. (1977). Improving patient compliance: A guide for physicians. Medical Clinics of North America, 61, 879-889.

    Mead, G. (1962). Mind, self, and society. Chicago: University of Chicago Press.

    Modigliani, E., Vasen, H., Raue, K., Dralle, H., Frilling, A., Gheri, R., et al. (1995). Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. Journal of Internal Medicine, 238, 363-376.

    Morse, J., & Field, P.A. (1995). Qualitative research methods for health professionals. Thousand Oaks, CA: Sage.

    Mulligan, L.M., Kwok, J.B., Healy, C.S., Elsdon, M.J., Eng, C., Gardner, E., et al. (1993). Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia syndrome type 2a. Nature, 376, 375-376.

    Neilson, A.R., & Whynes, D.K. (1995). Determinants of persistent compliance with screening for colorectal cancer. Social Science and Medicine, 41, 365-374.

    Pausova, Z., Soliman, E., Amizuka, N., Janicic, N., Konrad, E., Arnold, A., et al. (1996). Role of the RET proto-oncogene in sporadic hyperparathy-roidism and in hyperparathyroidism of multiple endocrine neoplasia 2. Journal of Clinical Endocrinology and Metabolism, 81, 2711-2718.

    Randolph, G.W., & Maniar, D. (2000). Medullary carcinoma of the thyroid. Cancer Control: Journal of the Moffitt Cancer Center, 7, 253-261.

    Raue, F. (1997). Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. In R. Sheaves, P. Jenkins, & J. Wass (Eds.), Clinical endocrine oncology (pp. 445-452). Cambridge, MA: Blackwell Science.

    Rechner, M. (1990). Adolescents with cancer: Getting on with life. Journal of Pediatric Oncology Nursing, 7, 139-144.

    Richards, L. (2000). NUD*IST N4 classic [Computer software]. Victoria, Australia: QSR International.

    Robinson, C.A. (1993). Managing life with a chronic condition: The story of normalization. Qualitative Health Research, 3(1), 6-28.

    Rolland, J.S. (1987). Chronic illness and the life cycle: A conceptual framework. Family Process, 26, 203-221.

    Rolland, J.S. (1990). Anticipatory loss: A family systems developmental framework. Family Process, 29, 229-244.

    Rolland, J.S. (1999). Families and genetic fate: A millennial challenge. Families, Systems, and Health, 17(1), 123-132.

    Schimke, R.N., & Hartmann, W.H. (1965). Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma. A distinct genetic entity. Annals of Internal Medicine, 63, 1027-1039.

    Skinner, M.A., DeBenedetti, M.K., Moley, J.F., Norton, J.A., & Wells, S.A., Jr. (1996). Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2a and 2b. Journal of Pediatric Surgery, 31, 177-182.

    Sober, E. (2000). The meaning of genetic causation. In A. Buchanan, D. Brock, N. Daniels, & D. Wilker (Eds.), From chance to choice: Genetics and justice (pp. 347-370). New York: Cambridge University Press.

    Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedure for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.

    Szubin, L., Kacker, A., Kakani, R., Komisar, A., & Blaugrund, A. (1996). The management of post-thyroidectomy hypocalcemia. Ear, Nose and Throat Journal, 75, 612-614, 616.

    Telander, R., Zimmerman, D., van Heerden, J., & Sizemore, G. (1986). Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2. Journal of Pediatric Surgery, 21, 1190-1194.

    Telenius-Berg, M., Ponder, M., Berg, B., Ponder, B., & Werner, S. (1989). Quality of life after bilateral adrenalectomy in MEN2. Henry Ford Hospital Medical Journal, 37, 160-163.

    Vernon, S.W., Gritz, E.R., Peterson, S.K., Amos, C.I., Perz, C.A., Baile, W.F., et al. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychology, 16, 73-86.

    Von Korff, M., Gruman, J., Schaefer, J., Curry, S.J., & Wagner, E.H. (1997). Collaborative management of chronic illness. Annals of Internal Medicine, 127, 1097-1102.

    Wells, S., Jr., Chi, D., Toshima, K., Dehner, L., Coffin, C., Dowton, S., et al. (1994). Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2a. Annals of Surgery, 220, 237-250.

    Wells, S.A., Jr., Baylin, S., Leight, G., Dale, J., Dilley, W., & Farndon, J. (1982). The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Annals of Surgery, 195, 596-599.